171 related articles for article (PubMed ID: 16189132)
1. Clevudine inhibits hepatitis delta virus viremia: a pilot study of chronically infected woodchucks.
Casey J; Cote PJ; Toshkov IA; Chu CK; Gerin JL; Hornbuckle WE; Tennant BC; Korba BE
Antimicrob Agents Chemother; 2005 Oct; 49(10):4396-9. PubMed ID: 16189132
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
Peek SF; Cote PJ; Jacob JR; Toshkov IA; Hornbuckle WE; Baldwin BH; Wells FV; Chu CK; Gerin JL; Tennant BC; Korba BE
Hepatology; 2001 Jan; 33(1):254-66. PubMed ID: 11124844
[TBL] [Abstract][Full Text] [Related]
3. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
Menne S; Cote PJ; Korba BE; Butler SD; George AL; Tochkov IA; Delaney WE; Xiong S; Gerin JL; Tennant BC
Antimicrob Agents Chemother; 2005 Jul; 49(7):2720-8. PubMed ID: 15980342
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-based gene therapy during clevudine treatment of woodchucks chronically infected with woodchuck hepatitis virus.
Zhu Y; Cullen JM; Aldrich CE; Saputelli J; Miller D; Seeger C; Mason WS; Jilbert AR
Virology; 2004 Sep; 327(1):26-40. PubMed ID: 15327895
[TBL] [Abstract][Full Text] [Related]
5. Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infection.
Jacquard AC; Nassal M; Pichoud C; Ren S; Schultz U; Guerret S; Chevallier M; Werle B; Peyrol S; Jamard C; Rimsky LT; Trepo C; Zoulim F
Antimicrob Agents Chemother; 2004 Jul; 48(7):2683-92. PubMed ID: 15215126
[TBL] [Abstract][Full Text] [Related]
6. Preclinical investigation of L-FMAU as an anti-hepatitis B virus agent.
Chu CK; Boudinot FD; Peek SF; Hong JH; Choi Y; Korba BE; Gerin JL; Cote PJ; Tennant BC; Cheng YC
Antivir Ther; 1998; 3(Suppl 3):113-21. PubMed ID: 10726061
[TBL] [Abstract][Full Text] [Related]
7. Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection.
Korba BE; Cote PJ; Menne S; Toshkov I; Baldwin BH; Wells FV; Tennant BC; Gerin JL
Antivir Ther; 2004 Dec; 9(6):937-52. PubMed ID: 15651753
[TBL] [Abstract][Full Text] [Related]
8. Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B.
Daffis S; Balsitis S; Chamberlain J; Zheng J; Santos R; Rowe W; Ramakrishnan D; Pattabiraman D; Spurlock S; Chu R; Kang D; Mish M; Ramirez R; Li L; Li B; Ma S; Hung M; Voitenleitner C; Yon C; Suresh M; Menne S; Cote P; Delaney WE; Mackman R; Fletcher SP
Hepatology; 2021 Jan; 73(1):53-67. PubMed ID: 32246499
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.
Le Guerhier F; Pichoud C; Jamard C; Guerret S; Chevallier M; Peyrol S; Hantz O; King I; Trépo C; Cheng YC; Zoulim F
Antimicrob Agents Chemother; 2001 Apr; 45(4):1065-77. PubMed ID: 11257017
[TBL] [Abstract][Full Text] [Related]
10. Chemoimmunotherapy of chronic hepatitis B virus infection in the woodchuck model overcomes immunologic tolerance and restores T-cell responses to pre-S and S regions of the viral envelope protein.
Menne S; Tennant BC; Gerin JL; Cote PJ
J Virol; 2007 Oct; 81(19):10614-24. PubMed ID: 17652398
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis.
Zhu Y; Yamamoto T; Cullen J; Saputelli J; Aldrich CE; Miller DS; Litwin S; Furman PA; Jilbert AR; Mason WS
J Virol; 2001 Jan; 75(1):311-22. PubMed ID: 11119601
[TBL] [Abstract][Full Text] [Related]
12. Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infection.
Menne S; Roneker CA; Tennant BC; Korba BE; Gerin JL; Cote PJ
Intervirology; 2002; 45(4-6):237-50. PubMed ID: 12566706
[TBL] [Abstract][Full Text] [Related]
13. Antiviral efficacy of lobucavir (BMS-180194), a cyclobutyl-guanosine nucleoside analogue, in the woodchuck (Marmota monax) model of chronic hepatitis B virus (HBV) infection.
Genovesi EV; Lamb L; Medina I; Taylor D; Seifer M; Innaimo S; Colonno RJ; Clark JM
Antiviral Res; 2000 Dec; 48(3):197-203. PubMed ID: 11164506
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans.
Korba BE; Cote P; Hornbuckle W; Tennant BC; Gerin JL
Hepatology; 2000 May; 31(5):1165-75. PubMed ID: 10796894
[TBL] [Abstract][Full Text] [Related]
15. Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.
Menne S; Asif G; Narayanasamy J; Butler SD; George AL; Hurwitz SJ; Schinazi RF; Chu CK; Cote PJ; Gerin JL; Tennant BC
Antimicrob Agents Chemother; 2007 Sep; 51(9):3177-84. PubMed ID: 17606676
[TBL] [Abstract][Full Text] [Related]
16. Apparent helper-independent infection of woodchucks by hepatitis delta virus and subsequent rescue with woodchuck hepatitis virus.
Netter HJ; Gerin JL; Tennant BC; Taylor JM
J Virol; 1994 Sep; 68(9):5344-50. PubMed ID: 8057418
[TBL] [Abstract][Full Text] [Related]
17. Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)-uracil (L-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection.
Menne S; Roneker CA; Korba BE; Gerin JL; Tennant BC; Cote PJ
J Virol; 2002 Jun; 76(11):5305-14. PubMed ID: 11991959
[TBL] [Abstract][Full Text] [Related]
18. Editing efficiency of hepatitis delta virus RNA is related to the course of infection in woodchucks.
Yang A; Karayiannis P; Thomas H; Monjardino J
J Gen Virol; 1995 Dec; 76 ( Pt 12)():3071-8. PubMed ID: 8847512
[TBL] [Abstract][Full Text] [Related]
19. Clevudine for the treatment of chronic hepatitis B virus infection.
Hui CK; Lau GK
Expert Opin Investig Drugs; 2005 Oct; 14(10):1277-84. PubMed ID: 16185170
[TBL] [Abstract][Full Text] [Related]
20. T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine.
Hervás-Stubbs S; Lasarte JJ; Sarobe P; Vivas I; Condreay L; Cullen JM; Prieto J; Borrás-Cuesta F
J Hepatol; 2001 Jul; 35(1):105-11. PubMed ID: 11495027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
